Chinanews.com, September 23. According to the official Weibo news of the Tianjin Municipal People’s Government Information Office, it was learned from the Tianjin CDC that from 18:00 to 22:00 on September 22, Tianjin added 1 newly imported confirmed case of new coronary pneumonia. , A total of 102 cases were reported (90 cases of Chinese nationality, 3 cases of American nationality, 7 cases of Filipino nationality, 1 case of French nationality, 1 case of Uzbekistan nationality), 95 cases were cured and discharged, and 7 cases were in hospital (including 5 cases of mild type and ordinary type) 2 cases).

  The 102nd imported confirmed case abroad, male, 55 years old, Chinese nationality, recent residence in Madrid, Spain.

The patient arrived at Tianjin Binhai International Airport by flight (CA908) from Madrid on September 20. His temperature was normal at the time of entry and declared asymptomatic.

After customs quarantine inspection and sampling, they will be transferred to the centralized isolation medical observation point in Wuqing District.

The nucleic acid test result of the new coronavirus in the customs laboratory on that day was negative.

The patient developed a cough at 7:30 on September 21, and an itchy throat at 20:30, accompanied by fever, with a body temperature of up to 38°C. The fever was accompanied by muscle soreness in both lower limbs and continuous upper abdominal pain. He was transferred by 120 ambulance Go to the Fever Clinic of Airport Hospital for treatment.

The patient's new coronavirus antibody IgM and IgG were negative, and the new coronavirus nucleic acid test results of nasal swabs and throat swabs were positive. Chest CT showed increased interstitial texture of both lungs, multiple cords in both lungs and dorsal sides of the lower lobes of the lungs Density shadow of ground glass.

After a comprehensive analysis by a municipal expert group, it was determined as a confirmed case (light type) of imported new coronary pneumonia in Tianjin.

He has been transferred to Haihe Hospital for treatment.

Implement closed-loop management throughout.